Skip to main content
رجوع
PCVX logo

Vaxcyte, Inc.

جودة البيانات: 100%
PCVX
NASDAQ Healthcare Biotechnology
KWD 54.67
▼ KWD 1.27 (-2.27%)
القيمة السوقية: 7.87B
نطاق اليوم
KWD 54.49 KWD 56.22
نطاق 52 أسبوعًا
KWD 27.66 KWD 75.33
حجم التداول
1,003,884
متوسط 50 يوم / 200 يوم
KWD 54.82 / KWD 42.62
الإغلاق السابق
KWD 55.94

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -10.3 0.4
P/B 2.9 2.9
ROE % -25.6 3.7
Net Margin % 3.9
Rev Growth 5Y % 10.0
D/E 0.1 0.2

السعر المستهدف للمحللين

Hold
KWD 83.000 +51.8%
Low: KWD 77.000 High: KWD 89.000
ربحية السهم المستقبلية
-KWD 7.178
الإيرادات المقدّرة
25 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 6.173
KWD 6.173 – KWD 6.173
2.3 B 2
FY2029 KWD 1.137
KWD 1.137 – KWD 1.137
1.4 B 4
FY2028 -KWD 5.948
-KWD 9.815 – -KWD 4.393
290 M 6

النقاط الرئيسية

Debt/Equity of 0.09 — conservative balance sheet
Negative free cash flow of -669.29M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-25.59%
ROIC-23.77%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
0.09
Current Ratio7.91
Interest Coverage0.00

التقييم

P/E Ratio
-10.26
P/B Ratio2.93
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -766.63M
ROE -25.59% ROA -25.17%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -669.29M
ROIC -23.77% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.09 Current Ratio 7.91
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio -10.26 P/B Ratio 2.93
P/S Ratio N/A PEG Ratio -0.17
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 7.87B Enterprise Value 7.92B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 0.0 0.0 0.0
Net Income -766.63M -463.93M -402.27M -223.49M -100.08M
EPS (Diluted) -5.63 -3.80 -4.14 -3.44 -1.93
Gross Profit 0.0 0.0 0.0 0.0 0.0
Operating Income -923.68M -569.55M -468.04M -232.26M -103.67M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 3.05B 3.51B 1.41B 1.01B 324.34M
Total Liabilities 360.46M 205.50M 167.45M 52.57M 40.32M
Shareholders' Equity 2.69B 3.31B 1.24B 953.61M 284.02M
Total Debt 228.84M 71.11M 29.22M 17.94M 16.78M
Cash & Equivalents 173.96M 387.88M 397.45M 834.66M 68.99M
Current Assets 1.63B 1.79B 1.10B 942.56M 256.35M
Current Liabilities 205.75M 140.18M 145.34M 40.53M 28.72M